BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 647392 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference 5-hydroxytryptamine receptor 2A Human 12.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647393 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Mitogen-activated protein kinase 12 Homo sapiens 344 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647394 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Glycogen synthase kinase-3 alpha Homo sapiens 45.0 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647395 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 5-hydroxytryptamine receptor 2A Human 60.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647396 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Mitogen-activated protein kinase 12 Homo sapiens 3739 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647397 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Glycogen synthase kinase-3 alpha Homo sapiens >17000 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647398 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-22-9-13-24(14-10-22)42-31(21-30(41-42)35(2,3)4)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-36-33(40-32)37-23-11-15-25(43)16-12-23/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) VFDXVDLISMVQFY-UHFFFAOYSA-N 330260 1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((3-hydroxyphenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 9::US10813932, Example 9::US9724347, Example 2::US9724347, Example 9::US9993478, Example 9 5-hydroxytryptamine receptor 2A Human 164 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330260&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547439 384575121 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647399 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-22-9-13-24(14-10-22)42-31(21-30(41-42)35(2,3)4)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-36-33(40-32)37-23-11-15-25(43)16-12-23/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) VFDXVDLISMVQFY-UHFFFAOYSA-N 330260 1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((3-hydroxyphenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 9::US10813932, Example 9::US9724347, Example 2::US9724347, Example 9::US9993478, Example 9 Mitogen-activated protein kinase 12 Homo sapiens 557 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330260&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547439 384575121 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647400 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-22-9-13-24(14-10-22)42-31(21-30(41-42)35(2,3)4)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-36-33(40-32)37-23-11-15-25(43)16-12-23/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) VFDXVDLISMVQFY-UHFFFAOYSA-N 330260 1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((3-hydroxyphenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 9::US10813932, Example 9::US9724347, Example 2::US9724347, Example 9::US9993478, Example 9 Glycogen synthase kinase-3 alpha Homo sapiens >1670 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330260&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547439 384575121 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647401 CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(O[*])cc1 330261 1-(3-(tert-butyl)-1-(4-hydroxyphenyl)-1H-pyrazol-5-yl)-3-(4-((2-(phenylamino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US9724347, Example 3 5-hydroxytryptamine receptor 2A Human 173 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330261&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647402 CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(O[*])cc1 330261 1-(3-(tert-butyl)-1-(4-hydroxyphenyl)-1H-pyrazol-5-yl)-3-(4-((2-(phenylamino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US9724347, Example 3 Mitogen-activated protein kinase 12 Homo sapiens 1503 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330261&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647403 CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(O[*])cc1 330261 1-(3-(tert-butyl)-1-(4-hydroxyphenyl)-1H-pyrazol-5-yl)-3-(4-((2-(phenylamino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US9724347, Example 3 Glycogen synthase kinase-3 alpha Homo sapiens 2494 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330261&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647404 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3F)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) YSCGLTBNMHIWFZ-UHFFFAOYSA-N 330262 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-fluorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 4::US10813932, Example 4::US9724347, Example 4::US9993478, Example 4 5-hydroxytryptamine receptor 2A Human 165 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330262&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547358 384575122 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647405 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3F)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) YSCGLTBNMHIWFZ-UHFFFAOYSA-N 330262 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-fluorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 4::US10813932, Example 4::US9724347, Example 4::US9993478, Example 4 Mitogen-activated protein kinase 12 Homo sapiens 8198 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330262&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547358 384575122 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647406 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3F)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) YSCGLTBNMHIWFZ-UHFFFAOYSA-N 330262 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-fluorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 4::US10813932, Example 4::US9724347, Example 4::US9993478, Example 4 Glycogen synthase kinase-3 alpha Homo sapiens >16600 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330262&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547358 384575122 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647407 COc1ccccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)n1 InChI=1S/C36H35N7O3/c1-23-14-16-24(17-15-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-27-18-19-29(26-11-7-6-10-25(26)27)46-33-20-21-37-34(41-33)38-28-12-8-9-13-30(28)45-5/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) OKZIGNXMBPUUKU-UHFFFAOYSA-N 330263 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 5::US10813932, Example 5::US9724347, Example 5::US9993478, Example 5 5-hydroxytryptamine receptor 2A Human 161 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330263&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547357 384575123 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647408 COc1ccccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)n1 InChI=1S/C36H35N7O3/c1-23-14-16-24(17-15-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-27-18-19-29(26-11-7-6-10-25(26)27)46-33-20-21-37-34(41-33)38-28-12-8-9-13-30(28)45-5/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) OKZIGNXMBPUUKU-UHFFFAOYSA-N 330263 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 5::US10813932, Example 5::US9724347, Example 5::US9993478, Example 5 Mitogen-activated protein kinase 12 Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330263&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547357 384575123 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647409 COc1ccccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)n1 InChI=1S/C36H35N7O3/c1-23-14-16-24(17-15-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-27-18-19-29(26-11-7-6-10-25(26)27)46-33-20-21-37-34(41-33)38-28-12-8-9-13-30(28)45-5/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) OKZIGNXMBPUUKU-UHFFFAOYSA-N 330263 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 5::US10813932, Example 5::US9724347, Example 5::US9993478, Example 5 Glycogen synthase kinase-3 alpha Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330263&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547357 384575123 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647410 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VKENGRJGQSSFDG-UHFFFAOYSA-N 330264 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chlorophenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 19::US10813932, Example 19::US9724347, Example 19::US9724347, Example 6::US9993478, Example 19 5-hydroxytryptamine receptor 2A Human 161 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330264&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547359 384575124 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647411 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VKENGRJGQSSFDG-UHFFFAOYSA-N 330264 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chlorophenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 19::US10813932, Example 19::US9724347, Example 19::US9724347, Example 6::US9993478, Example 19 Mitogen-activated protein kinase 12 Homo sapiens >16200 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330264&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547359 384575124 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647412 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VKENGRJGQSSFDG-UHFFFAOYSA-N 330264 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chlorophenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 19::US10813932, Example 19::US9724347, Example 19::US9724347, Example 6::US9993478, Example 19 Glycogen synthase kinase-3 alpha Homo sapiens >16200 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330264&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547359 384575124 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647413 COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-35(2,3)30-22-31(42(41-30)24-14-16-25(44-4)17-15-24)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)45-32-20-21-36-33(40-32)37-23-10-6-5-7-11-23/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) WMEVWPPRBPPTRV-UHFFFAOYSA-N 330265 1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-5-yl)-3-(4-((2-(phenylamino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 7::US9724347, Example 7::US9993478, Example 7 5-hydroxytryptamine receptor 2A Human 170 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330265&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547438 384575125 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647414 COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-35(2,3)30-22-31(42(41-30)24-14-16-25(44-4)17-15-24)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)45-32-20-21-36-33(40-32)37-23-10-6-5-7-11-23/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) WMEVWPPRBPPTRV-UHFFFAOYSA-N 330265 1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-5-yl)-3-(4-((2-(phenylamino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 7::US9724347, Example 7::US9993478, Example 7 Mitogen-activated protein kinase 12 Homo sapiens 1702 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330265&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547438 384575125 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647415 COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-35(2,3)30-22-31(42(41-30)24-14-16-25(44-4)17-15-24)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)45-32-20-21-36-33(40-32)37-23-10-6-5-7-11-23/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) WMEVWPPRBPPTRV-UHFFFAOYSA-N 330265 1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-5-yl)-3-(4-((2-(phenylamino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 7::US9724347, Example 7::US9993478, Example 7 Glycogen synthase kinase-3 alpha Homo sapiens 3505 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330265&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547438 384575125 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647416 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)c(C)c1 InChI=1S/C37H37N7O3/c1-23-11-13-25(14-12-23)44-33(22-32(43-44)37(3,4)5)41-36(45)40-30-17-18-31(28-10-8-7-9-27(28)30)47-34-19-20-38-35(42-34)39-29-16-15-26(46-6)21-24(29)2/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) VDENQWPWDDEUPY-UHFFFAOYSA-N 330266 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,4-dimethoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US9724347, Example 8 5-hydroxytryptamine receptor 2A Human 151 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330266&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 118360324 384575126 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647417 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)c(C)c1 InChI=1S/C37H37N7O3/c1-23-11-13-25(14-12-23)44-33(22-32(43-44)37(3,4)5)41-36(45)40-30-17-18-31(28-10-8-7-9-27(28)30)47-34-19-20-38-35(42-34)39-29-16-15-26(46-6)21-24(29)2/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) VDENQWPWDDEUPY-UHFFFAOYSA-N 330266 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,4-dimethoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US9724347, Example 8 Mitogen-activated protein kinase 12 Homo sapiens >15500 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330266&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 118360324 384575126 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647418 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)c(C)c1 InChI=1S/C37H37N7O3/c1-23-11-13-25(14-12-23)44-33(22-32(43-44)37(3,4)5)41-36(45)40-30-17-18-31(28-10-8-7-9-27(28)30)47-34-19-20-38-35(42-34)39-29-16-15-26(46-6)21-24(29)2/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) VDENQWPWDDEUPY-UHFFFAOYSA-N 330266 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,4-dimethoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US9724347, Example 8 Glycogen synthase kinase-3 alpha Homo sapiens >15500 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330266&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 118360324 384575126 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647419 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-22-9-13-24(14-10-22)42-31(21-30(41-42)35(2,3)4)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-36-33(40-32)37-23-11-15-25(43)16-12-23/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) VFDXVDLISMVQFY-UHFFFAOYSA-N 330260 1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((3-hydroxyphenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 9::US10813932, Example 9::US9724347, Example 2::US9724347, Example 9::US9993478, Example 9 5-hydroxytryptamine receptor 2A Human 171 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330260&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547439 384575121 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647420 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-22-9-13-24(14-10-22)42-31(21-30(41-42)35(2,3)4)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-36-33(40-32)37-23-11-15-25(43)16-12-23/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) VFDXVDLISMVQFY-UHFFFAOYSA-N 330260 1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((3-hydroxyphenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 9::US10813932, Example 9::US9724347, Example 2::US9724347, Example 9::US9993478, Example 9 Mitogen-activated protein kinase 12 Homo sapiens 760 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330260&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547439 384575121 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647421 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O3/c1-22-9-13-24(14-10-22)42-31(21-30(41-42)35(2,3)4)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-36-33(40-32)37-23-11-15-25(43)16-12-23/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) VFDXVDLISMVQFY-UHFFFAOYSA-N 330260 1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((3-hydroxyphenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 9::US10813932, Example 9::US9724347, Example 2::US9724347, Example 9::US9993478, Example 9 Glycogen synthase kinase-3 alpha Homo sapiens 3260 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330260&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547439 384575121 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647422 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)ccc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C37H37N7O2/c1-23-12-15-26(16-13-23)44-33(22-32(43-44)37(4,5)6)41-36(45)40-29-17-18-31(28-10-8-7-9-27(28)29)46-34-19-20-38-35(42-34)39-30-21-24(2)11-14-25(30)3/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) ONVRBAWIVFIJHQ-UHFFFAOYSA-N 330268 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,5-dimethylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 10::US10813932, Example 10::US9724347, Example 10::US9993478, Example 10 5-hydroxytryptamine receptor 2A Human 195 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330268&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547440 384575127 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647423 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)ccc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C37H37N7O2/c1-23-12-15-26(16-13-23)44-33(22-32(43-44)37(4,5)6)41-36(45)40-29-17-18-31(28-10-8-7-9-27(28)29)46-34-19-20-38-35(42-34)39-30-21-24(2)11-14-25(30)3/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) ONVRBAWIVFIJHQ-UHFFFAOYSA-N 330268 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,5-dimethylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 10::US10813932, Example 10::US9724347, Example 10::US9993478, Example 10 Mitogen-activated protein kinase 12 Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330268&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547440 384575127 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647424 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)ccc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C37H37N7O2/c1-23-12-15-26(16-13-23)44-33(22-32(43-44)37(4,5)6)41-36(45)40-29-17-18-31(28-10-8-7-9-27(28)29)46-34-19-20-38-35(42-34)39-30-21-24(2)11-14-25(30)3/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) ONVRBAWIVFIJHQ-UHFFFAOYSA-N 330268 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,5-dimethylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 10::US10813932, Example 10::US9724347, Example 10::US9993478, Example 10 Glycogen synthase kinase-3 alpha Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330268&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547440 384575127 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647425 Cc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C36H35N7O2/c1-23-10-14-25(15-11-23)38-34-37-21-20-33(41-34)45-30-19-18-29(27-8-6-7-9-28(27)30)39-35(44)40-32-22-31(36(3,4)5)42-43(32)26-16-12-24(2)13-17-26/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) CXRISVPNMXQWAR-UHFFFAOYSA-N 330269 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-(p-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 11::US10813932, Example 11::US9724347, Example 11::US9993478, Example 11 5-hydroxytryptamine receptor 2A Human 356 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330269&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547517 384575128 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647426 Cc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C36H35N7O2/c1-23-10-14-25(15-11-23)38-34-37-21-20-33(41-34)45-30-19-18-29(27-8-6-7-9-28(27)30)39-35(44)40-32-22-31(36(3,4)5)42-43(32)26-16-12-24(2)13-17-26/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) CXRISVPNMXQWAR-UHFFFAOYSA-N 330269 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-(p-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 11::US10813932, Example 11::US9724347, Example 11::US9993478, Example 11 Mitogen-activated protein kinase 12 Homo sapiens >16730 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330269&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547517 384575128 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647427 Cc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C36H35N7O2/c1-23-10-14-25(15-11-23)38-34-37-21-20-33(41-34)45-30-19-18-29(27-8-6-7-9-28(27)30)39-35(44)40-32-22-31(36(3,4)5)42-43(32)26-16-12-24(2)13-17-26/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) CXRISVPNMXQWAR-UHFFFAOYSA-N 330269 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-(p-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 11::US10813932, Example 11::US9724347, Example 11::US9993478, Example 11 Glycogen synthase kinase-3 alpha Homo sapiens >16700 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330269&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547517 384575128 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647428 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(C)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O2/c1-23-13-15-26(16-14-23)43-32(22-31(42-43)36(3,4)5)40-35(44)39-29-17-18-30(28-12-7-6-11-27(28)29)45-33-19-20-37-34(41-33)38-25-10-8-9-24(2)21-25/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) CKGGLZNZJRZRTM-UHFFFAOYSA-N 330270 1-(3-(tert-butyl)-1-(p-tolyl)-lH-pyrazol-5-yl)- 3-(4-((2-(m-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 12::US10813932, Example 12::US9724347, Example 12::US9993478, Example 12 5-hydroxytryptamine receptor 2A Human 169 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330270&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547518 384575129 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647429 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(C)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O2/c1-23-13-15-26(16-14-23)43-32(22-31(42-43)36(3,4)5)40-35(44)39-29-17-18-30(28-12-7-6-11-27(28)29)45-33-19-20-37-34(41-33)38-25-10-8-9-24(2)21-25/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) CKGGLZNZJRZRTM-UHFFFAOYSA-N 330270 1-(3-(tert-butyl)-1-(p-tolyl)-lH-pyrazol-5-yl)- 3-(4-((2-(m-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 12::US10813932, Example 12::US9724347, Example 12::US9993478, Example 12 Mitogen-activated protein kinase 12 Homo sapiens >16700 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330270&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547518 384575129 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647430 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(C)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O2/c1-23-13-15-26(16-14-23)43-32(22-31(42-43)36(3,4)5)40-35(44)39-29-17-18-30(28-12-7-6-11-27(28)29)45-33-19-20-37-34(41-33)38-25-10-8-9-24(2)21-25/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) CKGGLZNZJRZRTM-UHFFFAOYSA-N 330270 1-(3-(tert-butyl)-1-(p-tolyl)-lH-pyrazol-5-yl)- 3-(4-((2-(m-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 12::US10813932, Example 12::US9724347, Example 12::US9993478, Example 12 Glycogen synthase kinase-3 alpha Homo sapiens >16730 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330270&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547518 384575129 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647431 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(Cl)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-12-14-25(15-13-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-16-17-29(27-11-6-5-10-26(27)28)45-32-18-19-37-33(41-32)38-24-9-7-8-23(36)20-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) PWNRVPJJMBQUQF-UHFFFAOYSA-N 330271 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-chlorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 13::US10813932, Example 13::US9724347, Example 13::US9993478, Example 13 5-hydroxytryptamine receptor 2A Human 262 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330271&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547520 384575130 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647432 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(Cl)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-12-14-25(15-13-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-16-17-29(27-11-6-5-10-26(27)28)45-32-18-19-37-33(41-32)38-24-9-7-8-23(36)20-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) PWNRVPJJMBQUQF-UHFFFAOYSA-N 330271 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-chlorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 13::US10813932, Example 13::US9724347, Example 13::US9993478, Example 13 Mitogen-activated protein kinase 12 Homo sapiens >16200 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330271&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547520 384575130 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647433 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(Cl)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-12-14-25(15-13-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-16-17-29(27-11-6-5-10-26(27)28)45-32-18-19-37-33(41-32)38-24-9-7-8-23(36)20-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) PWNRVPJJMBQUQF-UHFFFAOYSA-N 330271 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-chlorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 13::US10813932, Example 13::US9724347, Example 13::US9993478, Example 13 Glycogen synthase kinase-3 alpha Homo sapiens >16200 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330271&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547520 384575130 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647434 COc1cccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)c1 InChI=1S/C36H35N7O3/c1-23-13-15-25(16-14-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-29-17-18-30(28-12-7-6-11-27(28)29)46-33-19-20-37-34(41-33)38-24-9-8-10-26(21-24)45-5/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) DQXDDNKSKQUYFA-UHFFFAOYSA-N 330272 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 14::US10813932, Example 14::US9724347, Example 14::US9993478, Example 14 5-hydroxytryptamine receptor 2A Human 119 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330272&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547519 384575131 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647435 COc1cccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)c1 InChI=1S/C36H35N7O3/c1-23-13-15-25(16-14-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-29-17-18-30(28-12-7-6-11-27(28)29)46-33-19-20-37-34(41-33)38-24-9-8-10-26(21-24)45-5/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) DQXDDNKSKQUYFA-UHFFFAOYSA-N 330272 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 14::US10813932, Example 14::US9724347, Example 14::US9993478, Example 14 Mitogen-activated protein kinase 12 Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330272&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547519 384575131 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647436 COc1cccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)c1 InChI=1S/C36H35N7O3/c1-23-13-15-25(16-14-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-29-17-18-30(28-12-7-6-11-27(28)29)46-33-19-20-37-34(41-33)38-24-9-8-10-26(21-24)45-5/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) DQXDDNKSKQUYFA-UHFFFAOYSA-N 330272 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 14::US10813932, Example 14::US9724347, Example 14::US9993478, Example 14 Glycogen synthase kinase-3 alpha Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330272&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547519 384575131 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647437 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(F)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-12-14-25(15-13-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-16-17-29(27-11-6-5-10-26(27)28)45-32-18-19-37-33(41-32)38-24-9-7-8-23(36)20-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) QJGQXNFWEATZQP-UHFFFAOYSA-N 330273 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3- (4-((2-((3-fluorophenyl)amino)pyrimidin- 4- yl)oxy)naphthalen-1-yl)urea::US10238658, Example 15::US10813932, Example 15::US9724347, Example 15::US9993478, Example 15 5-hydroxytryptamine receptor 2A Human 155 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330273&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547593 384575132 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647438 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(F)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-12-14-25(15-13-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-16-17-29(27-11-6-5-10-26(27)28)45-32-18-19-37-33(41-32)38-24-9-7-8-23(36)20-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) QJGQXNFWEATZQP-UHFFFAOYSA-N 330273 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3- (4-((2-((3-fluorophenyl)amino)pyrimidin- 4- yl)oxy)naphthalen-1-yl)urea::US10238658, Example 15::US10813932, Example 15::US9724347, Example 15::US9993478, Example 15 Mitogen-activated protein kinase 12 Homo sapiens >16600 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330273&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547593 384575132 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647439 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cccc(F)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-12-14-25(15-13-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-16-17-29(27-11-6-5-10-26(27)28)45-32-18-19-37-33(41-32)38-24-9-7-8-23(36)20-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) QJGQXNFWEATZQP-UHFFFAOYSA-N 330273 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3- (4-((2-((3-fluorophenyl)amino)pyrimidin- 4- yl)oxy)naphthalen-1-yl)urea::US10238658, Example 15::US10813932, Example 15::US9724347, Example 15::US9993478, Example 15 Glycogen synthase kinase-3 alpha Homo sapiens >16600 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330273&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547593 384575132 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647440 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(Cl)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-9-15-25(16-10-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-37-33(41-32)38-24-13-11-23(36)12-14-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) RBMBQMGGMMECLV-UHFFFAOYSA-N 330274 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-chlorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 16::US10813932, Example 16::US9724347, Example 16::US9993478, Example 16 5-hydroxytryptamine receptor 2A Human 616 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330274&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547596 384575133 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647441 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(Cl)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-9-15-25(16-10-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-37-33(41-32)38-24-13-11-23(36)12-14-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) RBMBQMGGMMECLV-UHFFFAOYSA-N 330274 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-chlorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 16::US10813932, Example 16::US9724347, Example 16::US9993478, Example 16 Mitogen-activated protein kinase 12 Homo sapiens >16200 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330274&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547596 384575133 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647442 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(Cl)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-9-15-25(16-10-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-37-33(41-32)38-24-13-11-23(36)12-14-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) RBMBQMGGMMECLV-UHFFFAOYSA-N 330274 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-chlorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 16::US10813932, Example 16::US9724347, Example 16::US9993478, Example 16 Glycogen synthase kinase-3 alpha Homo sapiens >16200 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330274&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547596 384575133 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647443 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C36H35N7O3/c1-23-10-14-25(15-11-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-29-18-19-30(28-9-7-6-8-27(28)29)46-33-20-21-37-34(41-33)38-24-12-16-26(45-5)17-13-24/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) AIRVOCDKJXGJQV-UHFFFAOYSA-N 330275 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 17::US10813932, Example 17::US9724347, Example 17::US9993478, Example 17 5-hydroxytryptamine receptor 2A Human 83.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330275&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547595 384575134 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647444 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C36H35N7O3/c1-23-10-14-25(15-11-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-29-18-19-30(28-9-7-6-8-27(28)29)46-33-20-21-37-34(41-33)38-24-12-16-26(45-5)17-13-24/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) AIRVOCDKJXGJQV-UHFFFAOYSA-N 330275 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 17::US10813932, Example 17::US9724347, Example 17::US9993478, Example 17 Mitogen-activated protein kinase 12 Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330275&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547595 384575134 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647445 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C36H35N7O3/c1-23-10-14-25(15-11-23)43-32(22-31(42-43)36(2,3)4)40-35(44)39-29-18-19-30(28-9-7-6-8-27(28)29)46-33-20-21-37-34(41-33)38-24-12-16-26(45-5)17-13-24/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) AIRVOCDKJXGJQV-UHFFFAOYSA-N 330275 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-methoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 17::US10813932, Example 17::US9724347, Example 17::US9993478, Example 17 Glycogen synthase kinase-3 alpha Homo sapiens >16300 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330275&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547595 384575134 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647446 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(Cl)cc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H34ClN7O2/c1-22-10-13-25(14-11-22)44-32(21-31(43-44)36(3,4)5)41-35(45)40-29-16-17-30(27-9-7-6-8-26(27)29)46-33-18-19-38-34(42-33)39-28-15-12-24(37)20-23(28)2/h6-21H,1-5H3,(H,38,39,42)(H2,40,41,45) HAKVAEKWYIEPSR-UHFFFAOYSA-N 330276 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-chloro-2-methylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 18::US10813932, Example 18::US9724347, Example 18::US9993478, Example 18 5-hydroxytryptamine receptor 2A Human 133 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330276&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547594 384575135 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647447 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(Cl)cc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H34ClN7O2/c1-22-10-13-25(14-11-22)44-32(21-31(43-44)36(3,4)5)41-35(45)40-29-16-17-30(27-9-7-6-8-26(27)29)46-33-18-19-38-34(42-33)39-28-15-12-24(37)20-23(28)2/h6-21H,1-5H3,(H,38,39,42)(H2,40,41,45) HAKVAEKWYIEPSR-UHFFFAOYSA-N 330276 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-chloro-2-methylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 18::US10813932, Example 18::US9724347, Example 18::US9993478, Example 18 Mitogen-activated protein kinase 12 Homo sapiens >15800 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330276&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547594 384575135 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647448 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(Cl)cc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H34ClN7O2/c1-22-10-13-25(14-11-22)44-32(21-31(43-44)36(3,4)5)41-35(45)40-29-16-17-30(27-9-7-6-8-26(27)29)46-33-18-19-38-34(42-33)39-28-15-12-24(37)20-23(28)2/h6-21H,1-5H3,(H,38,39,42)(H2,40,41,45) HAKVAEKWYIEPSR-UHFFFAOYSA-N 330276 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-chloro-2-methylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 18::US10813932, Example 18::US9724347, Example 18::US9993478, Example 18 Glycogen synthase kinase-3 alpha Homo sapiens >15800 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330276&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547594 384575135 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647449 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VKENGRJGQSSFDG-UHFFFAOYSA-N 330264 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chlorophenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 19::US10813932, Example 19::US9724347, Example 19::US9724347, Example 6::US9993478, Example 19 5-hydroxytryptamine receptor 2A Human 98.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330264&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547359 384575124 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647450 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VKENGRJGQSSFDG-UHFFFAOYSA-N 330264 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chlorophenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 19::US10813932, Example 19::US9724347, Example 19::US9724347, Example 6::US9993478, Example 19 Mitogen-activated protein kinase 12 Homo sapiens >15100 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330264&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547359 384575124 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647451 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O2/c1-22-13-15-23(16-14-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-27-17-18-29(25-10-6-5-9-24(25)27)45-32-19-20-37-33(41-32)38-28-12-8-7-11-26(28)36/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VKENGRJGQSSFDG-UHFFFAOYSA-N 330264 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chlorophenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 19::US10813932, Example 19::US9724347, Example 19::US9724347, Example 6::US9993478, Example 19 Glycogen synthase kinase-3 alpha Homo sapiens >15100 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330264&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547359 384575124 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647452 CC(C)c1ccccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)n1 InChI=1S/C38H39N7O2/c1-24(2)27-11-9-10-14-30(27)40-36-39-22-21-35(43-36)47-32-20-19-31(28-12-7-8-13-29(28)32)41-37(46)42-34-23-33(38(4,5)6)44-45(34)26-17-15-25(3)16-18-26/h7-24H,1-6H3,(H,39,40,43)(H2,41,42,46) AUNDYKNGIPQOPL-UHFFFAOYSA-N 330278 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-isopropylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 20::US10813932, Example 20::US9724347, Example 20::US9993478, Example 20 5-hydroxytryptamine receptor 2A Human 9.00 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330278&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547674 384575136 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647453 CC(C)c1ccccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)n1 InChI=1S/C38H39N7O2/c1-24(2)27-11-9-10-14-30(27)40-36-39-22-21-35(43-36)47-32-20-19-31(28-12-7-8-13-29(28)32)41-37(46)42-34-23-33(38(4,5)6)44-45(34)26-17-15-25(3)16-18-26/h7-24H,1-6H3,(H,39,40,43)(H2,41,42,46) AUNDYKNGIPQOPL-UHFFFAOYSA-N 330278 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-isopropylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 20::US10813932, Example 20::US9724347, Example 20::US9993478, Example 20 Mitogen-activated protein kinase 12 Homo sapiens >16000 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330278&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547674 384575136 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647454 CC(C)c1ccccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)n1 InChI=1S/C38H39N7O2/c1-24(2)27-11-9-10-14-30(27)40-36-39-22-21-35(43-36)47-32-20-19-31(28-12-7-8-13-29(28)32)41-37(46)42-34-23-33(38(4,5)6)44-45(34)26-17-15-25(3)16-18-26/h7-24H,1-6H3,(H,39,40,43)(H2,41,42,46) AUNDYKNGIPQOPL-UHFFFAOYSA-N 330278 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-isopropylphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 20::US10813932, Example 20::US9724347, Example 20::US9993478, Example 20 Glycogen synthase kinase-3 alpha Homo sapiens >16000 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330278&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547674 384575136 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647455 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O2/c1-23-14-16-25(17-15-23)43-32(22-31(42-43)36(3,4)5)40-35(44)39-29-18-19-30(27-12-8-7-11-26(27)29)45-33-20-21-37-34(41-33)38-28-13-9-6-10-24(28)2/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) IHAAICCNNPXTHZ-UHFFFAOYSA-N 330279 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-(o-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 21::US10813932, Example 21::US9724347, Example 21::US9993478, Example 21 5-hydroxytryptamine receptor 2A Human 33.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330279&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547675 384575137 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647456 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O2/c1-23-14-16-25(17-15-23)43-32(22-31(42-43)36(3,4)5)40-35(44)39-29-18-19-30(27-12-8-7-11-26(27)29)45-33-20-21-37-34(41-33)38-28-13-9-6-10-24(28)2/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) IHAAICCNNPXTHZ-UHFFFAOYSA-N 330279 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-(o-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 21::US10813932, Example 21::US9724347, Example 21::US9993478, Example 21 Mitogen-activated protein kinase 12 Homo sapiens >1670 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330279&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547675 384575137 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647457 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O2/c1-23-14-16-25(17-15-23)43-32(22-31(42-43)36(3,4)5)40-35(44)39-29-18-19-30(27-12-8-7-11-26(27)29)45-33-20-21-37-34(41-33)38-28-13-9-6-10-24(28)2/h6-22H,1-5H3,(H,37,38,41)(H2,39,40,44) IHAAICCNNPXTHZ-UHFFFAOYSA-N 330279 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-(o-tolylamino)pyrimidin-4-yl)oxy) naphthalen-1-yl)urea::US10238658, Example 21::US10813932, Example 21::US9724347, Example 21::US9993478, Example 21 Glycogen synthase kinase-3 alpha Homo sapiens >1670 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330279&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547675 384575137 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647458 CCOc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C37H37N7O3/c1-6-46-27-17-13-25(14-18-27)39-35-38-22-21-34(42-35)47-31-20-19-30(28-9-7-8-10-29(28)31)40-36(45)41-33-23-32(37(3,4)5)43-44(33)26-15-11-24(2)12-16-26/h7-23H,6H2,1-5H3,(H,38,39,42)(H2,40,41,45) CTDYPDKXAYTBGR-UHFFFAOYSA-N 330280 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-ethoxyphenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 22::US10813932, Example 22::US9724347, Example 22::US9993478, Example 22 5-hydroxytryptamine receptor 2A Human 281 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330280&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547676 384575138 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647459 CCOc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C37H37N7O3/c1-6-46-27-17-13-25(14-18-27)39-35-38-22-21-34(42-35)47-31-20-19-30(28-9-7-8-10-29(28)31)40-36(45)41-33-23-32(37(3,4)5)43-44(33)26-15-11-24(2)12-16-26/h7-23H,6H2,1-5H3,(H,38,39,42)(H2,40,41,45) CTDYPDKXAYTBGR-UHFFFAOYSA-N 330280 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-ethoxyphenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 22::US10813932, Example 22::US9724347, Example 22::US9993478, Example 22 Mitogen-activated protein kinase 12 Homo sapiens >1590 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330280&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547676 384575138 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647460 CCOc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1 InChI=1S/C37H37N7O3/c1-6-46-27-17-13-25(14-18-27)39-35-38-22-21-34(42-35)47-31-20-19-30(28-9-7-8-10-29(28)31)40-36(45)41-33-23-32(37(3,4)5)43-44(33)26-15-11-24(2)12-16-26/h7-23H,6H2,1-5H3,(H,38,39,42)(H2,40,41,45) CTDYPDKXAYTBGR-UHFFFAOYSA-N 330280 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-ethoxyphenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 22::US10813932, Example 22::US9724347, Example 22::US9993478, Example 22 Glycogen synthase kinase-3 alpha Homo sapiens >1590 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330280&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547676 384575138 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647461 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(F)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-9-15-25(16-10-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-37-33(41-32)38-24-13-11-23(36)12-14-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VBXDFGPLWMFEQW-UHFFFAOYSA-N 330281 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3- (4-((2-((4-fluorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 23::US10813932, Example 23::US9724347, Example 23::US9993478, Example 23 5-hydroxytryptamine receptor 2A Human 212 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330281&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547756 384575139 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647462 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(F)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-9-15-25(16-10-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-37-33(41-32)38-24-13-11-23(36)12-14-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VBXDFGPLWMFEQW-UHFFFAOYSA-N 330281 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3- (4-((2-((4-fluorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 23::US10813932, Example 23::US9724347, Example 23::US9993478, Example 23 Mitogen-activated protein kinase 12 Homo sapiens >1660 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330281&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547756 384575139 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647463 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(F)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O2/c1-22-9-15-25(16-10-22)43-31(21-30(42-43)35(2,3)4)40-34(44)39-28-17-18-29(27-8-6-5-7-26(27)28)45-32-19-20-37-33(41-32)38-24-13-11-23(36)12-14-24/h5-21H,1-4H3,(H,37,38,41)(H2,39,40,44) VBXDFGPLWMFEQW-UHFFFAOYSA-N 330281 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3- (4-((2-((4-fluorophenyl)amino)pyrimidin- 4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 23::US10813932, Example 23::US9724347, Example 23::US9993478, Example 23 Glycogen synthase kinase-3 alpha Homo sapiens >1660 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330281&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547756 384575139 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647464 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O3/c1-22-10-12-24(13-11-22)43-32(21-31(42-43)36(3,4)5)40-35(45)39-29-16-17-30(27-9-7-6-8-26(27)29)46-33-18-19-37-34(41-33)38-28-15-14-25(44)20-23(28)2/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) JLWQAVMMXAMIFK-UHFFFAOYSA-N 330282 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-hydroxy-2-methylphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 24::US10813932, Example 24::US9724347, Example 24::US9993478, Example 24 5-hydroxytryptamine receptor 2A Human 36.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330282&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547677 384575140 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647465 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O3/c1-22-10-12-24(13-11-22)43-32(21-31(42-43)36(3,4)5)40-35(45)39-29-16-17-30(27-9-7-6-8-26(27)29)46-33-18-19-37-34(41-33)38-28-15-14-25(44)20-23(28)2/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) JLWQAVMMXAMIFK-UHFFFAOYSA-N 330282 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-hydroxy-2-methylphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 24::US10813932, Example 24::US9724347, Example 24::US9993478, Example 24 Mitogen-activated protein kinase 12 Homo sapiens 695 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330282&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547677 384575140 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647466 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3C)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O3/c1-22-10-12-24(13-11-22)43-32(21-31(42-43)36(3,4)5)40-35(45)39-29-16-17-30(27-9-7-6-8-26(27)29)46-33-18-19-37-34(41-33)38-28-15-14-25(44)20-23(28)2/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) JLWQAVMMXAMIFK-UHFFFAOYSA-N 330282 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-hydroxy-2-methylphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 24::US10813932, Example 24::US9724347, Example 24::US9993478, Example 24 Glycogen synthase kinase-3 alpha Homo sapiens >1590 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330282&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547677 384575140 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647467 COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)ccc1O InChI=1S/C36H35N7O4/c1-22-10-13-24(14-11-22)43-32(21-31(42-43)36(2,3)4)40-35(45)39-27-15-17-29(26-9-7-6-8-25(26)27)47-33-18-19-37-34(41-33)38-23-12-16-28(44)30(20-23)46-5/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) VPQXOTKFLVTQBB-UHFFFAOYSA-N 330283 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-hydroxy-3-methoxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 25::US10813932, Example 25::US9724347, Example 25::US9993478, Example 25 5-hydroxytryptamine receptor 2A Human 77.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330283&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547758 384575141 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647468 COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)ccc1O InChI=1S/C36H35N7O4/c1-22-10-13-24(14-11-22)43-32(21-31(42-43)36(2,3)4)40-35(45)39-27-15-17-29(26-9-7-6-8-25(26)27)47-33-18-19-37-34(41-33)38-23-12-16-28(44)30(20-23)46-5/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) VPQXOTKFLVTQBB-UHFFFAOYSA-N 330283 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-hydroxy-3-methoxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 25::US10813932, Example 25::US9724347, Example 25::US9993478, Example 25 Mitogen-activated protein kinase 12 Homo sapiens 281 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330283&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547758 384575141 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647469 COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)ccc1O InChI=1S/C36H35N7O4/c1-22-10-13-24(14-11-22)43-32(21-31(42-43)36(2,3)4)40-35(45)39-27-15-17-29(26-9-7-6-8-25(26)27)47-33-18-19-37-34(41-33)38-23-12-16-28(44)30(20-23)46-5/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) VPQXOTKFLVTQBB-UHFFFAOYSA-N 330283 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((4-hydroxy-3-methoxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 25::US10813932, Example 25::US9724347, Example 25::US9993478, Example 25 Glycogen synthase kinase-3 alpha Homo sapiens >1590 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330283&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547758 384575141 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647470 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(C)c(O)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O3/c1-22-10-14-25(15-11-22)43-32(21-31(42-43)36(3,4)5)40-35(45)39-28-16-17-30(27-9-7-6-8-26(27)28)46-33-18-19-37-34(41-33)38-24-13-12-23(2)29(44)20-24/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) HICTUWNTIGIPDG-UHFFFAOYSA-N 330284 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-hydroxy-4-methylphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 26::US10813932, Example 26::US9724347, Example 26::US9993478, Example 26 5-hydroxytryptamine receptor 2A Human 549 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330284&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547757 384575142 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647471 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(C)c(O)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O3/c1-22-10-14-25(15-11-22)43-32(21-31(42-43)36(3,4)5)40-35(45)39-28-16-17-30(27-9-7-6-8-26(27)28)46-33-18-19-37-34(41-33)38-24-13-12-23(2)29(44)20-24/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) HICTUWNTIGIPDG-UHFFFAOYSA-N 330284 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-hydroxy-4-methylphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 26::US10813932, Example 26::US9724347, Example 26::US9993478, Example 26 Mitogen-activated protein kinase 12 Homo sapiens >1630 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330284&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547757 384575142 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647472 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(C)c(O)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C36H35N7O3/c1-22-10-14-25(15-11-22)43-32(21-31(42-43)36(3,4)5)40-35(45)39-28-16-17-30(27-9-7-6-8-26(27)28)46-33-18-19-37-34(41-33)38-24-13-12-23(2)29(44)20-24/h6-21,44H,1-5H3,(H,37,38,41)(H2,39,40,45) HICTUWNTIGIPDG-UHFFFAOYSA-N 330284 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-hydroxy-4-methylphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 26::US10813932, Example 26::US9724347, Example 26::US9993478, Example 26 Glycogen synthase kinase-3 alpha Homo sapiens >1630 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330284&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547757 384575142 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647473 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1OC InChI=1S/C37H37N7O4/c1-23-11-14-25(15-12-23)44-33(22-32(43-44)37(2,3)4)41-36(45)40-28-16-18-29(27-10-8-7-9-26(27)28)48-34-19-20-38-35(42-34)39-24-13-17-30(46-5)31(21-24)47-6/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) KNRZDHNOISHOGX-UHFFFAOYSA-N 330285 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3,4-dimethoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 27::US10813932, Example 27::US9724347, Example 27::US9993478, Example 27 5-hydroxytryptamine receptor 2A Human 105 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330285&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547759 384575143 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647474 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1OC InChI=1S/C37H37N7O4/c1-23-11-14-25(15-12-23)44-33(22-32(43-44)37(2,3)4)41-36(45)40-28-16-18-29(27-10-8-7-9-26(27)28)48-34-19-20-38-35(42-34)39-24-13-17-30(46-5)31(21-24)47-6/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) KNRZDHNOISHOGX-UHFFFAOYSA-N 330285 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3,4-dimethoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 27::US10813932, Example 27::US9724347, Example 27::US9993478, Example 27 Mitogen-activated protein kinase 12 Homo sapiens 535 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330285&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547759 384575143 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647475 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1OC InChI=1S/C37H37N7O4/c1-23-11-14-25(15-12-23)44-33(22-32(43-44)37(2,3)4)41-36(45)40-28-16-18-29(27-10-8-7-9-26(27)28)48-34-19-20-38-35(42-34)39-24-13-17-30(46-5)31(21-24)47-6/h7-22H,1-6H3,(H,38,39,42)(H2,40,41,45) KNRZDHNOISHOGX-UHFFFAOYSA-N 330285 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3,4-dimethoxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 27::US10813932, Example 27::US9724347, Example 27::US9993478, Example 27 Glycogen synthase kinase-3 alpha Homo sapiens 2108 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330285&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547759 384575143 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647476 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1Cl InChI=1S/C36H34ClN7O3/c1-22-10-13-24(14-11-22)44-32(21-31(43-44)36(2,3)4)41-35(45)40-28-15-17-29(26-9-7-6-8-25(26)28)47-33-18-19-38-34(42-33)39-23-12-16-30(46-5)27(37)20-23/h6-21H,1-5H3,(H,38,39,42)(H2,40,41,45) VOHADHHZHANGKB-UHFFFAOYSA-N 330286 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-chloro-4-methoxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 28::US10813932, Example 28::US9724347, Example 28::US9993478, Example 28 5-hydroxytryptamine receptor 2A Human 1422 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330286&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547843 384575144 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647477 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1Cl InChI=1S/C36H34ClN7O3/c1-22-10-13-24(14-11-22)44-32(21-31(43-44)36(2,3)4)41-35(45)40-28-15-17-29(26-9-7-6-8-25(26)28)47-33-18-19-38-34(42-33)39-23-12-16-30(46-5)27(37)20-23/h6-21H,1-5H3,(H,38,39,42)(H2,40,41,45) VOHADHHZHANGKB-UHFFFAOYSA-N 330286 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-chloro-4-methoxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 28::US10813932, Example 28::US9724347, Example 28::US9993478, Example 28 Mitogen-activated protein kinase 12 Homo sapiens >1540 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330286&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547843 384575144 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647478 COc1ccc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc1Cl InChI=1S/C36H34ClN7O3/c1-22-10-13-24(14-11-22)44-32(21-31(43-44)36(2,3)4)41-35(45)40-28-15-17-29(26-9-7-6-8-25(26)28)47-33-18-19-38-34(42-33)39-23-12-16-30(46-5)27(37)20-23/h6-21H,1-5H3,(H,38,39,42)(H2,40,41,45) VOHADHHZHANGKB-UHFFFAOYSA-N 330286 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-chloro-4-methoxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 28::US10813932, Example 28::US9724347, Example 28::US9993478, Example 28 Glycogen synthase kinase-3 alpha Homo sapiens >1540 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330286&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547843 384575144 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647479 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)c(F)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O3/c1-21-9-12-23(13-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-14-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-22-11-15-28(44)26(36)19-22/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) PDEVFPKHVTXCFJ-UHFFFAOYSA-N 330287 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-fluoro-4-hydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 29::US10813932, Example 29::US9724347, Example 29::US9993478, Example 29 5-hydroxytryptamine receptor 2A Human 311 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330287&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547842 384575145 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647480 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)c(F)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O3/c1-21-9-12-23(13-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-14-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-22-11-15-28(44)26(36)19-22/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) PDEVFPKHVTXCFJ-UHFFFAOYSA-N 330287 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-fluoro-4-hydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 29::US10813932, Example 29::US9724347, Example 29::US9993478, Example 29 Mitogen-activated protein kinase 12 Homo sapiens 423 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330287&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547842 384575145 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647481 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)c(F)c3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O3/c1-21-9-12-23(13-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-14-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-22-11-15-28(44)26(36)19-22/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) PDEVFPKHVTXCFJ-UHFFFAOYSA-N 330287 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((3-fluoro-4-hydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 29::US10813932, Example 29::US9724347, Example 29::US9993478, Example 29 Glycogen synthase kinase-3 alpha Homo sapiens >1620 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330287&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547842 384575145 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647482 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3F)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O3/c1-21-9-11-22(12-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-15-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-28-14-13-23(44)19-26(28)36/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) KPHLJVDHJFLLFQ-UHFFFAOYSA-N 330288 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-fluoro-4-hydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 30::US10813932, Example 30::US9724347, Example 30::US9993478, Example 30 5-hydroxytryptamine receptor 2A Human 68.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330288&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547841 384575146 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647483 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3F)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O3/c1-21-9-11-22(12-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-15-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-28-14-13-23(44)19-26(28)36/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) KPHLJVDHJFLLFQ-UHFFFAOYSA-N 330288 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-fluoro-4-hydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 30::US10813932, Example 30::US9724347, Example 30::US9993478, Example 30 Mitogen-activated protein kinase 12 Homo sapiens >1620 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330288&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547841 384575146 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647484 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3F)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32FN7O3/c1-21-9-11-22(12-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-15-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-28-14-13-23(44)19-26(28)36/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) KPHLJVDHJFLLFQ-UHFFFAOYSA-N 330288 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-fluoro-4-hydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 30::US10813932, Example 30::US9724347, Example 30::US9993478, Example 30 Glycogen synthase kinase-3 alpha Homo sapiens >1620 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330288&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547841 384575146 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647485 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O3/c1-21-9-11-22(12-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-15-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-28-14-13-23(44)19-26(28)36/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) FTOGPTPILJXAPZ-UHFFFAOYSA-N 330289 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chloro-4-hydroxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 31::US10813932, Example 31::US9724347, Example 31::US9993478, Example 31 5-hydroxytryptamine receptor 2A Human 118 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330289&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547844 384575147 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647486 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O3/c1-21-9-11-22(12-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-15-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-28-14-13-23(44)19-26(28)36/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) FTOGPTPILJXAPZ-UHFFFAOYSA-N 330289 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chloro-4-hydroxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 31::US10813932, Example 31::US9724347, Example 31::US9993478, Example 31 Mitogen-activated protein kinase 12 Homo sapiens >1580 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330289&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547844 384575147 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647487 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3Cl)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H32ClN7O3/c1-21-9-11-22(12-10-21)43-31(20-30(42-43)35(2,3)4)40-34(45)39-27-15-16-29(25-8-6-5-7-24(25)27)46-32-17-18-37-33(41-32)38-28-14-13-23(44)19-26(28)36/h5-20,44H,1-4H3,(H,37,38,41)(H2,39,40,45) FTOGPTPILJXAPZ-UHFFFAOYSA-N 330289 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2-chloro-4-hydroxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 31::US10813932, Example 31::US9724347, Example 31::US9993478, Example 31 Glycogen synthase kinase-3 alpha Homo sapiens >1580 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330289&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547844 384575147 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647488 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3O)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O4/c1-21-9-11-22(12-10-21)42-31(20-30(41-42)35(2,3)4)39-34(45)38-26-15-16-29(25-8-6-5-7-24(25)26)46-32-17-18-36-33(40-32)37-27-14-13-23(43)19-28(27)44/h5-20,43-44H,1-4H3,(H,36,37,40)(H2,38,39,45) NSYKHTWNGWUTST-UHFFFAOYSA-N 330290 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,4-dihydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 32::US10813932, Example 32::US9724347, Example 32::US9993478, Example 32 5-hydroxytryptamine receptor 2A Human 189 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330290&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547927 384575148 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647489 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3O)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O4/c1-21-9-11-22(12-10-21)42-31(20-30(41-42)35(2,3)4)39-34(45)38-26-15-16-29(25-8-6-5-7-24(25)26)46-32-17-18-36-33(40-32)37-27-14-13-23(43)19-28(27)44/h5-20,43-44H,1-4H3,(H,36,37,40)(H2,38,39,45) NSYKHTWNGWUTST-UHFFFAOYSA-N 330290 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,4-dihydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 32::US10813932, Example 32::US9724347, Example 32::US9993478, Example 32 Mitogen-activated protein kinase 12 Homo sapiens >1620 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330290&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547927 384575148 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647490 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3O)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O4/c1-21-9-11-22(12-10-21)42-31(20-30(41-42)35(2,3)4)39-34(45)38-26-15-16-29(25-8-6-5-7-24(25)26)46-32-17-18-36-33(40-32)37-27-14-13-23(43)19-28(27)44/h5-20,43-44H,1-4H3,(H,36,37,40)(H2,38,39,45) NSYKHTWNGWUTST-UHFFFAOYSA-N 330290 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)- 3-(4-((2-((2,4-dihydroxyphenyl)amino) pyrimidin-4-yl)oxy)naphthalen-1-yl)urea::US10238658, Example 32::US10813932, Example 32::US9724347, Example 32::US9993478, Example 32 Glycogen synthase kinase-3 alpha Homo sapiens >1620 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330290&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547927 384575148 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647491 COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O4/c1-35(2,3)30-21-31(42(41-30)23-11-15-25(45-4)16-12-23)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)46-32-19-20-36-33(40-32)37-22-9-13-24(43)14-10-22/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) YEMXWTXOSTZPEB-UHFFFAOYSA-N 330291 1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-5-yl)-3-(4-((2-((4-hydroxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 33::US10813932, Example 33::US9724347, Example 33::US9993478, Example 33 5-hydroxytryptamine receptor 2A Human 60.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330291&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547928 384575149 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647492 COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O4/c1-35(2,3)30-21-31(42(41-30)23-11-15-25(45-4)16-12-23)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)46-32-19-20-36-33(40-32)37-22-9-13-24(43)14-10-22/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) YEMXWTXOSTZPEB-UHFFFAOYSA-N 330291 1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-5-yl)-3-(4-((2-((4-hydroxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 33::US10813932, Example 33::US9724347, Example 33::US9993478, Example 33 Mitogen-activated protein kinase 12 Homo sapiens 264 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330291&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547928 384575149 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647493 COc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccc(O)cc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O4/c1-35(2,3)30-21-31(42(41-30)23-11-15-25(45-4)16-12-23)39-34(44)38-28-17-18-29(27-8-6-5-7-26(27)28)46-32-19-20-36-33(40-32)37-22-9-13-24(43)14-10-22/h5-21,43H,1-4H3,(H,36,37,40)(H2,38,39,44) YEMXWTXOSTZPEB-UHFFFAOYSA-N 330291 1-(3-(tert-butyl)-1-(4-methoxyphenyl)-1H- pyrazol-5-yl)-3-(4-((2-((4-hydroxyphenyl) amino)pyrimidin-4-yl)oxy)naphthalen-1- yl)urea::US10238658, Example 33::US10813932, Example 33::US9724347, Example 33::US9993478, Example 33 Glycogen synthase kinase-3 alpha Homo sapiens 2377 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=330291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=330291&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547928 384575149 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647494 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Proto-oncogene tyrosine-protein kinase Src Human 22.0 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 647495 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Tyrosine-protein kinase SYK Homo sapiens 334 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 647496 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Proto-oncogene tyrosine-protein kinase Src Human 5.00 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 647497 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Tyrosine-protein kinase SYK Homo sapiens 42.0 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 647498 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 5-hydroxytryptamine receptor 2A Human 20.0 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647499 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Mitogen-activated protein kinase 12 Homo sapiens 43.0 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647500 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Tyrosine-protein kinase HCK Homo sapiens 8.00 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4465&target=Tyrosine-protein+kinase+HCK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Tyrosine-protein+kinase+HCK&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MGGRSSCEDPGCPRDEERAPRMGCMKSKFLQVGGNTFSKTETSASPHCPVYVPDPTSTIKPGPNSHNSNTPGIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQQQP 2HK5,2OI3,2OJ2,4HCK,4U5W,5HCK,5ZJ6 Tyrosine-protein kinase HCK HCK_HUMAN P08631 A8K1I1 B4DQB6 E1P5M2 Q29RX1 Q2VPE2 Q504R5 Q5T7K1 Q5T7K2 Q96CC0 Q9H5Y5 Q9NUA4 Q9UMJ5 647501 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Proto-oncogene tyrosine-protein kinase Src Human 10.00 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 647502 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Tyrosine-protein kinase SYK Homo sapiens 14.0 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 647503 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Glycogen synthase kinase-3 alpha Homo sapiens 20000 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647504 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C InChI=1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) DBXJNQABFNNKPN-UHFFFAOYSA-N 161376 US10238658, Example 1::US10813932, Example 1::US9108950, 1::US9724347, Example 1::US9993478, Example 1 Glycogen synthase kinase-3 beta Homo sapiens 1200 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1003&target=Glycogen+synthase+kinase-3+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=161376&enzyme=Glycogen+synthase+kinase-3+beta&column=ki&startPg=0&Increment=50&submit=Search 71547929 295370025 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST 1GNG,1I09,1J1B,1J1C,1PYX,1Q3D,1Q3W,1Q41,1Q4L,1Q5K,1R0E,2JLD,2O5K,2OW3,3DU8,3F7Z,3GB2,3I4B,3L1S,3M1S,3PUP,3Q3B,3SAY,3SD0,3ZDI,3ZRK,3ZRL,3ZRM,4ACC,4ACD,4ACG,4ACH,4AFJ,4B7T,4IQ6,4J1R,4J71,4NM0,4NM3,4NM5,4NM7,4NU1,4PTC,4PTE,4PTG,5F94,5F95,5HLN,5HLP,5K5N,5KPK,5KPL,5KPM,5OY4,6B8J,6GJO,6GN1,6H0U,6HK3,6HK4,6HK7,6TCU,6V6L,6Y9R,6Y9S,7B6F,7OY5,7SXH,7SXJ,7U2Z,7U31,7U33,7U36,7Z1F,7Z1G,8AUZ,8AV1,8DJC,8DJD,8DJE,8FF8 Glycogen synthase kinase-3 beta GSK3B_HUMAN P49841 D3DN89 Q9BWH3 Q9UL47 647505 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference 5-hydroxytryptamine receptor 2A Human 1.000 US Patent 10.7270/Q2MC923K aid1796831 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 6WHA,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 647506 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Mitogen-activated protein kinase 12 Homo sapiens 5.00 US Patent 10.7270/Q2MC923K aid1796832 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6337&target=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Mitogen-activated+protein+kinase+12&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 1CM8,7CGA Mitogen-activated protein kinase 12 MK12_HUMAN P53778 Q14260 Q6IC53 Q99588 Q99672 647507 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Tyrosine-protein kinase HCK Homo sapiens 5.00 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4465&target=Tyrosine-protein+kinase+HCK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Tyrosine-protein+kinase+HCK&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MGGRSSCEDPGCPRDEERAPRMGCMKSKFLQVGGNTFSKTETSASPHCPVYVPDPTSTIKPGPNSHNSNTPGIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQQQP 2HK5,2OI3,2OJ2,4HCK,4U5W,5HCK,5ZJ6 Tyrosine-protein kinase HCK HCK_HUMAN P08631 A8K1I1 B4DQB6 E1P5M2 Q29RX1 Q2VPE2 Q504R5 Q5T7K1 Q5T7K2 Q96CC0 Q9H5Y5 Q9NUA4 Q9UMJ5 647508 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Proto-oncogene tyrosine-protein kinase Src Human 4.00 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 647509 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Tyrosine-protein kinase SYK Homo sapiens 9.00 US Patent 10.7270/Q2MC923K aid1796834 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 647510 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Glycogen synthase kinase-3 alpha Homo sapiens 180 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 647511 COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(C)cc3)C(C)(C)C)c3ccccc23)ccn1 InChI=1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) AVUUHIYJPTWYNX-UHFFFAOYSA-N 142598 US10238658, Example Reference::US10813932, Reference Compound::US8933228, Ref 2::US9242960, 1::US9249125, Reference Compound::US9701670, Reference Compound::US9724347, Example Reference::US9993478, Example Reference Glycogen synthase kinase-3 beta Homo sapiens 24.0 US Patent 10.7270/Q2MC923K aid1796833 US9724347 Ito, K; Charron, CE; King-Underwood, J; Onions, ST; Longshaw, AI 8/8/2017 6/12/2019 Respivert Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=142598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1003&target=Glycogen+synthase+kinase-3+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=142598&enzyme=Glycogen+synthase+kinase-3+beta&column=ki&startPg=0&Increment=50&submit=Search 46218331 251964228 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST 1GNG,1I09,1J1B,1J1C,1PYX,1Q3D,1Q3W,1Q41,1Q4L,1Q5K,1R0E,2JLD,2O5K,2OW3,3DU8,3F7Z,3GB2,3I4B,3L1S,3M1S,3PUP,3Q3B,3SAY,3SD0,3ZDI,3ZRK,3ZRL,3ZRM,4ACC,4ACD,4ACG,4ACH,4AFJ,4B7T,4IQ6,4J1R,4J71,4NM0,4NM3,4NM5,4NM7,4NU1,4PTC,4PTE,4PTG,5F94,5F95,5HLN,5HLP,5K5N,5KPK,5KPL,5KPM,5OY4,6B8J,6GJO,6GN1,6H0U,6HK3,6HK4,6HK7,6TCU,6V6L,6Y9R,6Y9S,7B6F,7OY5,7SXH,7SXJ,7U2Z,7U31,7U33,7U36,7Z1F,7Z1G,8AUZ,8AV1,8DJC,8DJD,8DJE,8FF8 Glycogen synthase kinase-3 beta GSK3B_HUMAN P49841 D3DN89 Q9BWH3 Q9UL47